News from us and our partners

Tags

Topics

0 results

News
1 February, 2023
Prof. Jacques Séguin, renowned inventor of CoreValve, joins Endoron Medical as Chairman of the Board
News
26 January, 2023
AFYREN chooses Thailand for its second biobased organic acids plant, entering a partnership project with Mitr Phol, a global leader in the sugar industry
News
24 January, 2023
Amolyt Pharma signs research agreement and license option with XOMA
News
23 January, 2023
Julier Medical raises €3 million in seed financing from Sofinnova Partners to treat patients with acute ischemic stroke
News
19 January, 2023
PinCell announces the development of a key transgenic mouse model and the appointment of Dr. Antonino Amato as CEO
News
17 January, 2023
Shockwave Medical announces agreement to acquire Neovasc
Feature
16 January, 2023
For our team, investment is about impact
News
10 January, 2023
AFYREN adds new hires to support growth in France and expansion abroad
News
9 January, 2023
CinCor Pharma to be acquired by AstraZeneca
News
8 January, 2023
Sofinnova Partners Chair sees opportunity on the horizon
News
6 January, 2023
Amolyt Pharma announces $138 million Series C financing led by Sofinnova Partners and co-led by Intermediate Capital Group
News
5 January, 2023
Sofinnova Partners welcomes Mano Iyer as Venture Partner
News
5 January, 2023
Inspirna announces interim data from Phase 1b/2 study of Abequolixron (RGX-104) in relapsed or refractory lung cancer
News
3 January, 2023
MaxCyte signs strategic platform license with Catamaran Bio to support its CAR-NK cell therapy programs
News
22 December, 2022
Lilly and ProQR to expand RNA editing collaboration
News
20 December, 2022
Elicit Plant awarded up to €7.5 M funding from the European Commission through the EIC Accelerator program for deep tech start-ups

Prof. Jacques Séguin, renowned inventor of CoreValve, joins Endoron Medical as Chairman of the Board

AFYREN chooses Thailand for its second biobased organic acids plant, entering a partnership project with Mitr Phol, a global leader in the sugar industry

Amolyt Pharma signs research agreement and license option with XOMA

Julier Medical raises €3 million in seed financing from Sofinnova Partners to treat patients with acute ischemic stroke

PinCell announces the development of a key transgenic mouse model and the appointment of Dr. Antonino Amato as CEO

Shockwave Medical announces agreement to acquire Neovasc

For our team, investment is about impact

AFYREN adds new hires to support growth in France and expansion abroad

CinCor Pharma to be acquired by AstraZeneca

Sofinnova Partners Chair sees opportunity on the horizon

Amolyt Pharma announces $138 million Series C financing led by Sofinnova Partners and co-led by Intermediate Capital Group

Sofinnova Partners welcomes Mano Iyer as Venture Partner

Inspirna announces interim data from Phase 1b/2 study of Abequolixron (RGX-104) in relapsed or refractory lung cancer

MaxCyte signs strategic platform license with Catamaran Bio to support its CAR-NK cell therapy programs

Lilly and ProQR to expand RNA editing collaboration

Elicit Plant awarded up to €7.5 M funding from the European Commission through the EIC Accelerator program for deep tech start-ups